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Abstract GCM proteins constitute a small transcription factor
family. Nuclear localization of Drosophila GCM is mediated by
a typical bipartite nuclear localization sequence (NLS) close to
the DNA-binding GCM domain. Here, we have analyzed nu-
clear localization of the mammalian GCM proteins. Whereas
GCMb/Gcm-2 contained a classical bipartite NLS, nuclear lo-
calization of GCMa/Gcm-1 was mediated by two regions with-
out resemblance to known NLS, one corresponding to the ami-
no-terminal part of the GCM domain, the second de¢ned as a
tyrosine-and-proline-rich carboxy-terminal region. Nuclear im-
port was counteracted by an amino-terminal nuclear export ac-
tivity. This complex regulation of subcellular localization has
important implications for GCMa/Gcm-1 function.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
GCM (glial cells missing) proteins constitute a separate
family of transcription factors [1]. The hallmark of all GCM
proteins is the GCM domain [2], a zinc-coordinating,
L-pleated sheet containing DNA-binding domain with a novel
fold and mode of DNA recognition [3,4]. GCM proteins are
present in vertebrates and some invertebrates, but appear to
be absent in plants and fungi. Compared to other transcrip-
tion factor families, the number of GCM proteins in a given
species is low [4]. Thus, there are two GCM proteins in Dro-
sophila melanogaster [5], and two GCM proteins in mammals
[1].
All GCM proteins show highly similar DNA-binding char-
acteristics and recognize a 5P-ATGCGGGT-3P consensus mo-
tif or minor variations thereof [2,6,7]. However, GCM pro-
teins fail to show signi¢cant sequence similarities outside the
GCM domain, including functionally important regions such
as the respective transactivation domains [7^9]. In addition to
this low amount of sequence conservation, there also seems to
be a lack of functional conservation [1]. The two Drosophila
GCM proteins play essential and partially redundant roles in
gliogenesis of the developing nervous system and in hemocyte
development [10^14], whereas the two mammalian homologs
GCMa/Gcm-1 and GCMb/Gcm-2 are important for placental
and parathyroid development, respectively [15^17]. GCMa/
Gcm-1 (henceforth called GCMa) is additionally expressed
in thymus and kidney [18].
Being transcription factors, GCM proteins are expected to
be primarily nuclear, and should contain nuclear localization
signals (NLS). In transcription factors, NLS are frequently
located within the DNA-binding domain or its immediate
vicinity [19]. Sometimes, two functionally independent NLS
have been mapped in a single transcription factor [20]. NLS
are recognized by importin K/L heterodimers. Complexes be-
tween importins and cargo proteins are then targeted to the
nuclear pore complex through which translocation of the im-
portin-bound protein occurs in a manner dependent on the
guanine nucleotide binding protein Ran and several Ran-in-
teracting factors [21,22].
In some proteins, nuclear import is counteracted by a nu-
clear export mechanism that often involves a small, hydro-
phobic, leucine-rich nuclear export signal (NES) in the cargo
protein [23,24], and the NES-interacting factor CRM1 [25,26].
Proteins containing both NLS and NES have the capacity to
continuously shuttle between the cytoplasm and the nucleus.
We have previously mapped the NLS of Drosophila GCM
to a short stretch of amino acids (KR-X10-KRRR) between
position 218 and 233 of the protein [8]. This NLS conforms to
the consensus for bipartite NLS in which two clusters of basic
amino acids are separated by a stretch of 10^12 amino acids
[27]. It closely follows the DNA-binding GCM domain (ami-
no acids 34^186), and thus occupies a position typical for an
NLS in transcription factors. Analogously, the mammalian
GCMb/Gcm-2 contains a putative NLS consisting of two ba-
sic clusters separated by nine amino acids which is situated
immediately behind the GCM domain [28], but still has to be
veri¢ed experimentally.
Sequence inspection of GCMa, in contrast, did not reveal
any obvious candidate for an NLS with any of the commonly
used prediction programs. We therefore set out to experimen-
tally de¢ne the requirements for nuclear import of GCMa.
2. Materials and methods
2.1. Plasmid constructs
Full-length mouse GCMa, a GCMa variant with an internal dele-
tion of amino acids 312^337 and several carboxy-terminally truncated
versions (GCMa1^400; GCMa1^176) were fused to an amino-termi-
nal T7 epitope and inserted between BamHI and SalI sites of pCMV5.
In addition to wild-type GCMa, non-DNA-binding mutants (K74M
and C76A, see [4,6]) were used. An expression plasmid for a green
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£uorescent protein (GFP)-GCMa fusion protein was generated by
inserting the wild-type GCMa coding region between XhoI and EcoRI
sites of pEGFP-N1 (Clontech Laboratories, Palo Alto, CA, USA). All
L-galactosidase expression plasmids were based on the previously de-
scribed pCMVlacZ [29], so that various fragments of mouse GCMa
(see Figs. 2^4) or the region encompassing amino acids 176^189 of
mouse GCMb/Gcm-2 (KRQMASFYQPQKRR) could be added to
the 5P end of the lacZ gene. A lacZ fusion carrying the NLS from
SV40 T-antigen was used as positive control [29]. Fragments corre-
sponding to amino acids 1^72 or amino acids 68^120 of mouse GCMa
were also placed between the BamHI and NheI sites of pGEX-GFP so
that GCMa sequences were inserted in frame between glutathione
S-transferase (GST) and GFP [30].
2.2. Tissue culture, transfection, immunocytochemistry and
X-Gal staining
HeLa and NIH 3T3 cells were maintained in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) containing 10% fetal calf serum. HeLa cells
were transfected in 35 mm plates using Superfect reagent (Qiagen).
Forty-eight hours post transfection, cells were ¢xed using 1% para-
formaldehyde and either stained for L-galactosidase activity in phos-
phate-bu¡ered saline containing 1 mg/ml X-Gal or processed for
immunocytochemistry [18] using a mouse monoclonal antibody di-
rected against the T7 epitope (Novagen) and Cy3-coupled goat anti-
mouse antibodies (Dianova), both diluted 1:200.
2.3. Puri¢cation and microinjection of GST-GFP fusion proteins
GST-GFP hybrid proteins were expressed in Escherichia coli BL21,
puri¢ed on glutathione Sepharose 4B (Pharmacia Biotech, Germany),
concentrated by ultra¢ltration with a Nanosep ¢lter (Pall-Filtron,
USA) and microinjected into nuclei or cytoplasm of HeLa cells at
1.5 mg/ml in combination with rabbit IgG (1.0 mg/ml) using a Com-
piC INJECT computer-assisted injection system (Cellbiology Trading,
Hamburg, Germany) as described [30]. Cells were ¢xed 1.5 h post
injection with 3% paraformaldehyde, and the injected proteins were
analyzed by immuno£uorescence analysis.
2.4. Heterokaryon assays and immuno£uorescence studies
Nucleocytoplasmic shuttling of GCMa was analyzed in a hetero-
karyon assay [31]. Brie£y, transfected HeLa cells were seeded on glass
coverslips together with an equal number of NIH 3T3 cells. Cells were
incubated with 50 Wg/ml cycloheximide 30 min prior to the fusion and
throughout the experiment. Heterokaryons were formed by incubating
the cells for 2 min in 50% polyethylene glycol 8000 in DMEM. After
2 h incubation at 37‡C in the presence of cycloheximide, cells were
¢xed, processed for indirect immuno£uorescence analysis, counter-
stained with 5 Wg/ml of Hoechst 33258 (Sigma, Taufkirchen, Ger-
many) and analyzed as described [30].
3. Results
3.1. Subcellular localization of mouse GCMa
To directly visualize the subcellular localization of GCMa,
we transfected HeLa cells with an epitope-tagged version of
mouse GCMa and performed immunocytochemistry on the
transfected cells using an antibody directed against the ami-
no-terminal T7 epitope. Most of the GCMa protein was lo-
calized to the nuclei of transfected cells as expected (Fig. 1a).
Even GCMa mutants that were unable to bind to DNA due
to exchange of an essential residue in the GCM domain were
still predominantly nuclear (Fig. 1b) indicating that DNA
binding and nuclear localization are separable functions.
Moreover, shortening the protein by 36 amino acids from
the carboxy-terminal end did not alter the subcellular local-
ization arguing that GCMa does not need to be intact to
correctly localize in cells (Fig. 1c). However, further shorten-
ing to a version that essentially corresponds to the GCM
domain (amino acids 1^176) altered subcellular distribution.
The GCM domain was only partially localized to the nucleus;
a signi¢cant portion remained cytoplasmic (Fig. 1d). The rel-
ative amount of nuclear GCM domain was even further re-
duced when DNA binding was prevented by substitution of
an essential amino acid (Fig. 1e). We conclude from the di¡er-
ent subcellular distribution of full-length GCMa and the
GCM domain that an important determinant for nuclear lo-
calization must be localized outside the GCM domain. Fur-
thermore, if we assume active transport of the GCM domain
into the nucleus, it must contain a signal for nuclear import.
This nuclear import signal either functions ine⁄ciently or is
counteracted by a simultaneously present export function. The
fact that a higher fraction of the GCM domain is nuclear in
the presence of intact DNA binding could argue in favor of
an additional export function, as retention of the GCM do-
main on DNA would decrease the rate of nuclear export and
alter the relative subcellular distribution at steady state.
3.2. Mapping the NLS outside the GCM domain
Commonly used prediction programs failed to detect typical
nuclear localization signals within GCMa. For NLS identi¢-
cation we divided GCMa into ¢ve, slightly overlapping frag-
ments (F1^F5, Fig. 2a) and fused them in frame to L-galac-
tosidase. The subcellular distribution of these L-galactosidase
fusions in transfected HeLa cells was determined by X-Gal
staining. Unfused L-galactosidase was predominantly cyto-
plasmic and served as a control (L-gal in Fig. 2b). GCMa
fragments F2, F3 and F5 exhibited cytoplasmic localizations
(Fig. 2b). Fragment F1, in contrast, was both nuclear and
cytoplasmic, indicating that the determinants for subcellular
localization which might be present within the GCM domain
Fig. 1. Subcellular localization of wild-type and mutant mGCMa.
Indirect immuno£uorescence studies of HeLa cells transfected with
the following T7 epitope-tagged GCMa proteins: (a) full-length
wild-type GCMa, (b) full-length non-DNA-binding GCMa (C76A
mutant), (c) carboxy-terminal GCMa deletion mutant (residues
1^400), (d) wild-type GCM domain (residues 1^176), (e) non-DNA-
binding GCM domain (K74M mutant), (e) internal GCMa deletion
mutant lacking amino acids 312^337 (GCMavNLS). Antibodies di-
rected against the amino-terminal T7 epitope were used for detec-
tion.
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(see Fig. 1d) should be localized to the ¢rst 72 amino acids.
Only fragment F4, which encompassed amino acids 196^389,
was able to drive the overwhelming amount of L-galactosidase
fusion into the nucleus in a manner comparable to the NLS of
SV40 T-antigen (compare F4 to NLS-LGal in Fig. 2b). There-
fore, we conclude that an NLS is present in the GCMa region
represented by fragment F4.
To de¢ne this NLS in more detail, we subdivided fragment
F4 further (Fig. 3a). The ¢rst series of subfragments that were
fused to L-galactosidase consisted of three fragments spanning
amino acids 196^270 (F4/1), amino acids 271^311 (F4/2), and
amino acids 312^389 (F4/3). Again, only one of the resulting
L-galactosidase fusions (i.e. the one containing fragment F4/3)
exhibited predominantly nuclear localization (Fig. 3b).
A further set of L-galactosidase fusions with di¡erent parts
of the region between amino acids 312 and 389 of GCMa was
generated and analyzed in transfected HeLa cells for their
subcellular localization (fragments F4/3a^F4/3e in Fig. 4a).
Only fragments F4/3b and F4/3e which contained the region
immediately following amino acid residue 312 exhibited nu-
clear localization, the shortest of which was fragment F4/3e
with a length of 25 amino acids spanning positions 312^337
(Fig. 4b). Fusions between L-galactosidase and GCMa frag-
ments starting at later amino acid positions such as residue
331 (F4/3c), residue 337 (F4/3d) or residue 354 (F4/3a) stayed
predominantly cytoplasmic. Thus, we have experimentally de-
¢ned the 25 amino acids contained within F4/3e as the NLS of
GCMa. Basic amino acids were completely missing. Instead,
the NLS was rich in tyrosine, proline, serine and leucine res-
idues (Fig. 4a).
Nuclear localization of L-galactosidase was also achieved
when the putative NLS of GCMb/Gcm-2 was fused to the
amino-terminus of lacZ instead of GCMa sequences
(GCMb NLS in Fig. 4b). In direct comparison, the NLS of
GCMb/Gcm-2 appeared to be somewhat more e⁄cient in
translocating L-galactosidase to the nucleus than the minimal
Fig. 2. NLS-carrying regions of GCMa. a: Domain structure of
mouse GCMa with DNA-binding GCM domain (DNA-BD) and
two transactivation domains (TA1 and TA2) as well as schematic
representation of the GCMa fragments F1^F5 that were fused to
the amino-terminus of L-galactosidase. Numbers indicate ¢rst and
last residues present in protein domains or GCMa fragments.
b: X-Gal staining of HeLa cells transfected with L-galactosidase fu-
sions carrying the GCMa fragments depicted in panel a. LGal, L-ga-
lactosidase control for cytoplasmic localization. NLS-LGal, L-galac-
tosidase carrying the NLS of SV40 T-antigen at its amino-terminus,
control for nuclear localization.
Fig. 3. Mapping the carboxy-terminal NLS of GCMa. a: Domain
structure of mouse GCMa with DNA-binding GCM domain
(DNA-BD) and two transactivation domains (TA1 and TA2) as
well as schematic representation of the GCMa fragments F4/1^F4/3
that were fused to the amino-terminus of L-galactosidase. Numbers
indicate ¢rst and last residues present in protein domains or GCMa
fragments. b: X-Gal staining of HeLa cells transfected with L-galac-
tosidase fusions carrying the GCMa fragments depicted in panel a.
Not shown are the LGal and NLS-LGal controls which were per-
formed in parallel.
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NLS from GCMa as evident from the fact that residual cy-
toplasmic L-galactosidase staining was still visible with the
GCMa NLS, but not with the GCMb NLS.
To con¢rm the importance of amino acids 312^337 for
nuclear localization of GCMa, we generated a GCMa mutant
in which this region was selectively deleted. This GCMavNLS
mutant exhibited cytoplasmic as well as nuclear localization
contrasting with the predominantly nuclear localization of
wild-type GCMa (Fig. 1f). This altered subcellular distribu-
tion of the GCMavNLS mutant is unlikely to result from a
severely disturbed overall conformation because it is still able
to activate a GCM-dependent reporter plasmid in a manner
very similar to the wild-type protein (data not shown). Its
behavior clearly corroborates the importance of the NLS at
residues 312^337 of GCMa for nuclear localization. However,
it also argues for a second NLS within GCMa. Taking all
experiments (see Figs. 1 and 2) into consideration, this com-
ponent is most likely localized in the ¢rst 72 amino acids of
GCMa.
3.3. Analyzing the role of the GCM domain in subcellular
localization of GCMa
To directly address this question we performed microinjec-
tion experiments with a bacterially expressed fusion protein
carrying amino acids 1^72 of GCMa sandwiched between a
GST and a GFP portion (GST-F1-GFP in Fig. 5a). Injection
sites were marked by co-injection of IgG (right panels in Fig.
5b^d). When injected into the cytoplasm, the fusion protein
e⁄ciently translocated into the nucleus con¢rming the pres-
ence of an NLS in this GCMa fragment (Fig. 5b, left panel).
After nuclear injection, on the other hand, a signi¢cant frac-
Fig. 4. Delineating the carboxy-terminal NLS of GCMa. a: Sche-
matic representation of the GCMa fragments F4/3a^F4/3e that were
fused to the amino-terminus of L-galactosidase. Numbers indicate
¢rst and last residues present in GCMa fragments. The amino acid
sequence of the NLS of GCMa (corresponding to residues 312^337)
is shown. b: X-Gal staining of HeLa cells transfected with L-galac-
tosidase fusions carrying the GCMa fragments depicted in panel a
or amino acids 176^189 of GCMb/Gcm-2 (GCMb NLS). Not
shown are the LGal and NLS-LGal controls which were performed
in parallel.
Fig. 5. Nuclear import and export functions of the amino-terminal
GCMa region. a: Schematic representation of the GST-GFP fusion
proteins carrying residues 1^72 (GST-F1-GFP) or residues 68^120
(GST-F2-GFP) of GCMa. b^d: Indirect immuno£uorescence analy-
sis of HeLa cells 1.5 h after microinjection with GST-GFP fusion
proteins depicted in panel a and IgG. Left panels shown the GST-
GFP fusions, right panels the co-injected IgG. b: Cytoplasmic mi-
croinjection, GST-F1-GFP. c: Nuclear microinjection, GST-F1-
GFP. d: Cytoplasmic (arrow) and nuclear (arrowhead) microinjec-
tion, GST-F2-GFP.
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tion of the fusion protein found its way into the cytoplasm
arguing that amino acids 1^72 of GCMa also contain an ex-
port signal (Fig. 5c, left panel). As a control, we injected an
analogous fusion protein carrying amino acids 68^120 of
GCMa instead of amino acids 1^72. Similar to the co-injected
IgG, this fusion protein remained in the subcellular compart-
ment where it was injected independent of whether it was
injected into the cytoplasm (arrow in Fig. 5d, left panel) or
into the nucleus (arrowhead in Fig. 5d, left panel).
If GCMa contains NLS and NES sequences it should be
able to relocate between cytoplasm and nucleus. To analyze
this question, an interspecies heterokaryon analysis was per-
formed. HeLa cells were cotransfected with a GFP-GCMa
expression plasmid and an NLS-L-galactosidase control plas-
mid (Fig. 6a) that encodes a nucleus-restricted L-galactosidase
(see Fig. 2b). Transfected cells were allowed to synthesize the
ectopic proteins. Prior to and following heterokaryon forma-
tion (lower right panel in Fig. 6b) de novo protein synthesis
was inhibited. In these heterokarya, human nuclei can be dif-
ferentiated from murine nuclei by staining with Hoechst 33258
dye which yields a characteristic punctate pattern in murine
nuclei and a di¡use stain in human nuclei (upper left panel in
Fig. 6b). Two hours after heterokaryon formation, only GFP-
GCMa was found to be present in both human and murine
nuclei (upper right panel in Fig. 6b), whereas NLS-L-galacto-
sidase was detected exclusively in the human nuclei (lower left
panel in Fig. 6b). GFP-GCMa was thus selectively trans-
ported from the transfected HeLa cell nucleus into the cyto-
plasm and subsequently into the murine nucleus. We conclude
that GCMa is able to leave and enter the nucleus and there-
fore constitutes a bona ¢de nucleocytoplasmic shuttling pro-
tein.
4. Discussion
From the fact that GCMa as a transcription factor has to
function in the nucleus, it is expected to possess an NLS.
Because of their characteristic signature, NLS are quite e¡ec-
tively predicted by computer algorithms as was the case for
Drosophila GCM and GCMb/Gcm-2. In both proteins, the
NLS is in the immediate vicinity of the DNA-binding GCM
domain. Such proximity between NLS and DNA-binding do-
main is often observed in transcription factors and can be
explained in evolutionary terms as ensuring co-segregation
of two intimately linked characteristics.
In the case of GCMa, prediction programs failed to detect
an NLS, thus making experimental de¢nition necessary. In
this study, we mapped two NLS within GCMa. One of these
NLS is localized in the ¢rst 72 amino acids of the protein and
thus within the GCM domain. The ¢rst 50 of these 72 amino
acids either appear disordered in the crystal structure or are
localized on the solvent-exposed surface of the GCM domain
[4]. Therefore, they should be easily accessible for the nuclear
import and export machinery. The second NLS was found
closer to the carboxy-terminus between two regions that had
previously been shown to function as transactivation domains
[9]. No other function has previously been ascribed to this
carboxy-terminal NLS-containing region.
Identi¢cation of the amino-terminal NLS was confounded
by the simultaneous presence of an NES in the same frag-
ment. While the nature and sequence of the amino-terminal
NLS as well as its degree of conservation in other GCM
proteins are di⁄cult to predict at the moment, there is a
good candidate for an NES in the same region. Residues
14^23 (LSWDINDVKL) conform roughly to the L-X23-L-
X23-L-X-L/I consensus for small, hydrophobic, leucine-rich
NES [32]. Comparative sequence analysis between GCMa and
other GCM proteins indicates that this putative NES is not
conserved in other GCM proteins.
Our data indicate that GCMa is a nucleocytoplasmic shut-
tling protein whose overall subcellular distribution depends on
the activity of two NLS and one NES. Accordingly, deletion
of one of the NLS allocates a greater proportion of mGCMa
to the cytoplasm. The ability to shuttle might also be impor-
tant for its function, as it might render GCMa responsive to
cytoplasmic signaling events. Nucleocytoplasmic shuttling of-
fers a unique opportunity for additional modulation of
GCMa activity as well as for protein sequestration. Previous
detection of a minor fraction of the endogenous GCMa pro-
tein in the cytoplasm of placental trophoblasts [33] might be
taken as evidence that nucleocytoplasmic shuttling is indeed
relevant for GCMa function in vivo. Interestingly, Drosophila
GCM has also been reported to be nuclear in glioblasts of the
£y embryo, but cytoplasmic in neuroglioblasts [34] arguing
that nucleocytoplasmic shuttling might be a conserved feature
within this family of transcription factors.
Astonishing is the absence of any similarity between known
NLS and either NLS of GCMa. The NLS of GCMa thus
Fig. 6. Nucleocytoplasmic shuttling of GCMa. a: Schematic repre-
sentation of GFP-GCMa and NLS-LGal proteins. b: Heterokaryon
assay between HeLa cells cotransfected with expression plasmids for
the proteins shown in panel a and 3T3 cells. Two hours later, cells
were ¢xed, stained for LGal and counterstained with Hoechst 33258
dye (upper left panel). Murine nuclei are marked by an arrow. In
interspecies heterokaryons that coexpressed GFP-GCMa and NLS-
LGal, only GFP-GCMa was found in the murine nuclei (upper right
panel), while NLS-LGal was restricted exclusively to the human nu-
clei (lower left panel). Heterokaryon in phase contrast (lower right
panel).
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constitute highly unusual and novel nuclear import signals.
Instead of basic residues, the most prominent amino acids
within the carboxy-terminal NLS were tyrosines, prolines, ser-
ines and leucines. The overrepresentation of tyrosines and
serines in the carboxy-terminal NLS of GCMa might indicate
that this region undergoes phosphorylation in vivo which
could in£uence its function as an NLS and thereby alter the
overall distribution of GCMa in the cell. Several NLS have
indeed been shown in the past to be modulated in their e⁄-
cacy by phosphorylation sites within the NLS or in its imme-
diate vicinity [35^37].
Many features indicate that GCM transcription factors
arose late during evolution and have not expanded as much
as most other transcription factor families [1]. The unusual
NLS of GCMa might be yet another indicator of a relative
young evolutionary age, as GCMa structure might not have
had the time to be streamlined to a typical transcription fac-
tor. Alternatively, the particular features of NLS and NES
may directly result from functional restraints imposed on
GCMa. This will only be unravelled once a better understand-
ing has been achieved of the molecular function of GCMa.
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